🇺🇸 FDA
Patent

US 11224577

Treating infection by a platelet-targeting microbe using nanoparticles

granted A61KA61K2300/00A61K31/337

Quick answer

US patent 11224577 (Treating infection by a platelet-targeting microbe using nanoparticles) held by The Regents of the University of California expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2300/00, A61K31/337, A61K31/7042, A61K45/06